Arthur Lau

Arthur Lau is a Project Manager at Arch Biopartners and a Research Scientist in Dr. Daniel Muruve’s research program. He completed a B.Sc. with Honours at the University of Toronto and a Ph.D. at the University of Western Ontario with a focus on kidney transplantation and immunology. As a postdoctoral fellow at the University of Calgary under the mentorship of Dr. Muruve, he continued his research on acute kidney injury and immunology including publications describing the use of LSALT peptide in renal disease. His current research focus is on elucidating mechanisms of immune surveillance in the kidney and developing therapeutics against acute kidney injury. Arthur joined the Arch Biopartners’ team as a Project Manager primarily managing the development of the LSALT peptide/Metablok portfolio and its related technologies.